.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Mallinckrodt
Queensland Health
Boehringer Ingelheim
Cantor Fitzgerald
Johnson and Johnson
McKesson
Cerilliant
US Army
Covington

Generated: February 18, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Patent: 05016291

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Novo Nordisk IncNORDITROPIN FLEXPROsomatropin recombinantINJECTABLE;INJECTION021148-008Mar 1, 2010BXRXNoNo➤ Try a Free Trial➤ Try a Free TrialY
Novo Nordisk IncNORDITROPIN FLEXPROsomatropin recombinantINJECTABLE;INJECTION021148-009Mar 1, 2010BXRXNoNo➤ Try a Free Trial➤ Try a Free TrialY
Novo Nordisk IncNORDITROPIN FLEXPROsomatropin recombinantINJECTABLE;INJECTION021148-010Mar 1, 2010RXNoNo➤ Try a Free Trial➤ Try a Free TrialY
Novo Nordisk IncNORDITROPIN FLEXPROsomatropin recombinantINJECTABLE;INJECTION021148-011Jan 23, 2015RXNoNo➤ Try a Free Trial➤ Try a Free TrialY
Novo Nordisk IncLEVEMIR FLEXTOUCHinsulin detemir recombinantINJECTABLE;SUBCUTANEOUS021536-005Oct 31, 2013RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
Novo Nordisk IncNOVOLOG FLEXTOUCHinsulin aspart recombinantINJECTABLE;SUBCUTANEOUS020986-005Oct 31, 2013RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
Novo Nordisk IncFIASP FLEXTOUCHinsulin aspartSOLUTION;SUBCUTANEOUS208751-002Sep 29, 2017RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
Novo Nordisk IncOZEMPICsemaglutideSOLUTION;SUBCUTANEOUS209637-001Dec 5, 2017RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
Novo Nordisk IncRYZODEG 70/30insulin aspart; insulin degludecSOLUTION;SUBCUTANEOUS203313-001Sep 25, 2015RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
Novo Nordisk IncSAXENDAliraglutide recombinantSOLUTION;SUBCUTANEOUS206321-001Dec 23, 2014RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist